HK1257586A1 - 預防和治療腎纖維化的藥物及其用途 - Google Patents

預防和治療腎纖維化的藥物及其用途

Info

Publication number
HK1257586A1
HK1257586A1 HK18116705.2A HK18116705A HK1257586A1 HK 1257586 A1 HK1257586 A1 HK 1257586A1 HK 18116705 A HK18116705 A HK 18116705A HK 1257586 A1 HK1257586 A1 HK 1257586A1
Authority
HK
Hong Kong
Prior art keywords
medicine
preventing
kidney fibrosis
treating kidney
treating
Prior art date
Application number
HK18116705.2A
Other languages
English (en)
Inventor
李季男
Original Assignee
深圳瑞健生命科學研究院有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 深圳瑞健生命科學研究院有限公司 filed Critical 深圳瑞健生命科學研究院有限公司
Publication of HK1257586A1 publication Critical patent/HK1257586A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/484—Plasmin (3.4.21.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21007—Plasmin (3.4.21.7), i.e. fibrinolysin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK18116705.2A 2016-12-15 2018-12-28 預防和治療腎纖維化的藥物及其用途 HK1257586A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201611162257 2016-12-15
CN201611162270 2016-12-15

Publications (1)

Publication Number Publication Date
HK1257586A1 true HK1257586A1 (zh) 2019-10-25

Family

ID=62658161

Family Applications (3)

Application Number Title Priority Date Filing Date
HK18116709.8A HK1257590A1 (zh) 2016-12-15 2018-12-28 預防和治療藥物性腎損傷的藥物及其用途
HK18116710.5A HK1257591A1 (zh) 2016-12-15 2018-12-28 預防和治療病理性腎組織損傷的藥物及其用途
HK18116705.2A HK1257586A1 (zh) 2016-12-15 2018-12-28 預防和治療腎纖維化的藥物及其用途

Family Applications Before (2)

Application Number Title Priority Date Filing Date
HK18116709.8A HK1257590A1 (zh) 2016-12-15 2018-12-28 預防和治療藥物性腎損傷的藥物及其用途
HK18116710.5A HK1257591A1 (zh) 2016-12-15 2018-12-28 預防和治療病理性腎組織損傷的藥物及其用途

Country Status (2)

Country Link
CN (3) CN108210893A (zh)
HK (3) HK1257590A1 (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201902419D0 (en) * 2019-02-22 2019-04-10 Singapore Health Serv Pte Ltd Treatment of kidney injury
CA3169325A1 (en) * 2020-02-26 2021-09-02 Jinan Li Method and drug for preventing and treating abnormal blood pressure condition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2496258B1 (en) * 2009-11-07 2016-11-02 Astute Medical, Inc. Methods for diagnosis and prognosis of renal injury and renal failure

Also Published As

Publication number Publication date
CN108210893A (zh) 2018-06-29
HK1257590A1 (zh) 2019-10-25
CN108210894A (zh) 2018-06-29
CN108210908A (zh) 2018-06-29
HK1257591A1 (zh) 2019-10-25

Similar Documents

Publication Publication Date Title
HK1258396A1 (zh) 用於治療纖維化的賽尼克韋羅聯合療法
IL250960A0 (en) Combined treatment of sinecriviroc for the treatment of leprosy
ZA201607415B (en) Antibody-drug-conjugate and its use for the treatment of cancer
IL260771B1 (en) Catheter closure solution and catheter closure treatment
LT3227237T (lt) Įrenginys ir jo naudojimas skysčiams apdoroti ultravioletiniais spinduliais
HK1258276A1 (zh) 用於治療hiv的化合物和組合
IL265955A (en) Therapeutic compounds and methods of use thereof
ZA201904331B (en) Fluid treatment systems and methods of using the same
HK1247963A1 (zh) 用於hiv的治療的基因療法及其用途
GB201617064D0 (en) Compounds and their therapeutic use
HK1249851A1 (zh) 使用聚維酮碘的普通感冒的治療和預防
HK1257239A1 (zh) 預防和治療肥胖症的藥物及其用途
HK1257587A1 (zh) 預防和治療肝纖維化的藥物及其用途
GB201715194D0 (en) Compounds and their therapeutic use
IL265824A (en) Methods and pharmaceutical compositions for the treatment of kidney cancer
EP3723742C0 (fr) Utilisation de la fluoroethylnormemantine pour la prevention et le traitement de l'anxiete
HK1255695A1 (zh) 用於治療眼瞼下垂的組合物和方法
HK1257586A1 (zh) 預防和治療腎纖維化的藥物及其用途
HK1257238A1 (zh) 預防和治療脂質腎損傷的藥物及其用途
EP3525771A4 (en) PREVENTION AND / OR TREATMENT OF ACUTE RENAL FAILURE INDUCED BY CONTRAST AGENTS
EP3217997A4 (en) Dab2 inhibitors for the prevention and treatment of cystic fibrosis
EP3490604C0 (en) MEDICATION FOR THE TREATMENT AND/OR PREVENTION OF ENDOMETRIOSIS
GB201403086D0 (en) Selection of virus and agent useful in the treatment of cancer